Change in weight-for-length status during the first three months: relationships to birth weight and implications for

Rich May1, Daniel Kim, Debbie Mote-Watson

  • 1Biology Department, Southern Oregon University, Ashland, OR 97520, USA. mayr@sou.edu

Insights

Infants with lower birth weight gained weight-for-length, while higher birth weight infants saw decreases. These early changes may indicate maladaptive adjustments to feeding environments.

Area of Science:

  • Pediatric Nutrition
  • Growth Monitoring
  • Metabolic Health

Background:

  • Early postnatal weight-for-length is crucial for predicting later body composition and metabolic risk.
  • Understanding infant growth trajectories based on birth weight is essential for early health interventions.

Purpose of the Study:

  • To analyze changes in weight-for-length status in early infancy, stratified by birth weight.
  • To investigate the influence of birth weight, feeding practices, and ethnicity on infant growth patterns.

Main Methods:

  • Utilized data from 267 infants in the Jackson County WIC program, with measurements taken between birth and 12 weeks.
  • Calculated changes in WHO z-scores for weight, length, and weight-for-length from birth to the clinic visit.
  • Employed multiple regression models to assess predictors and moderators of z-score changes, including birth weight, demographics, and feeding type (breastfed vs. formula-fed).

Main Results:

  • Infants with lower birth weight showed an increase in weight-for-length z-scores, associated with increased weight z-scores but not length z-scores.
  • Higher birth weight infants exhibited decreased weight and length z-scores, with no significant change in weight-for-length z-scores.
  • Hispanic ethnicity was linked to decreased length z-scores and increased weight-for-length z-scores, without moderating birth weight effects.

Conclusions:

  • Weight-for-length changes in early infancy vary significantly by birth weight, potentially reflecting phenotypic adjustments.
  • Increased weight-for-length in lower birth weight infants and persistent high weight-for-length in higher birth weight infants may be maladaptive in certain dietary environments.
  • These findings highlight the importance of monitoring infant growth trajectories in relation to birth weight for identifying potential metabolic risks.

Related Concept Videos

Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...